NHN Godo gears up to go public on Kosdaq Shopping mall solution developer distributes RFPs to brokerages
Translated by Kim So-in 공개 2021-04-20 07:52:52
이 기사는 2021년 04월 20일 07:46 thebell 에 표출된 기사입니다.
South Korea’s shopping mall solution developer NHN Godo is aiming to go public on the Kosdaq amid booming ecommerce business.NHN Godo sent out a request for proposals (RFP) to domestic major brokerage firms to make its stock market debut, industry sources said on Friday. The company plans to complete the selection process by this month to begin its initial public offering (IPO) preparations in earnest.
The IPO timing has not been decided, but it is likely to speed up the process given that ecommerce companies are starting to get spotlights in the IPO market recently.
NHN Godo is an ecommerce company that was separated from the nation’s tech giant Naver in 2003. Its largest shareholder is NHN, with a 90.33% stake. A fund managed by Keistone Partners is the second largest shareholder.
A shopping mall solution refers to a program necessary to operate an online shopping mall. It is a complex service including product management, ordering, and payment. Main clients include retail companies which intend to expand their business from offline to online.
NHN Godo recorded revenue of 33.2 billion won ($29 million) and operating income of 5.8 billion won in 2020 thanks to the rapid ecommerce growth. If this trend continues into the first half of this year, the company is likely to be valued at its target level.
Market insiders said NHN Godo may be valued at around 1 trillion won given the rapid growth of ecommerce business. If it is valued at the level, Keistone Partners is expected to generate returns of more than six times invested capital.
Keistone Partners acquired 4,945 common shares and 11,927 preferred shares in 2019 through a rights offering. At that time, Keistone Partners valued 100% of NHN Godo at around 150 billion won. (Reporting by Cheol Kang)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '사랑의열매' OCIO, NH증권 수성 여부 촉각
- 다올운용 라인업 확대 '총력'…해외재간접 펀드 출시
- [스튜어드십코드 모니터]브이아이운용, 현대엘리 표대결서 이사회측 손들었다
- [스튜어드십코드 모니터]다올운용, 삼성전자 이사 후보 '리스크 관리 미흡'
- [성과연동 펀드판매 확산]당국 눈치보며 쉬쉬…법령해석 재확인후 '본격화' 조짐
- [동구바이오제약 신사업 전략]캐시카우만으론 역부족, 벌크업 기반 '오너 보증 차입'
- [LK삼양 뉴비기닝]그룹 오너 구본욱의 변신, 경쟁력 강화만 본다
- [루키 바이오텍 in market]김권 셀비온 대표"경쟁약 넘는 효능, 품목허가 꿈 도전"
- [Policy Radar]바이오시밀러 문턱 낮춘 유럽, 비용·경쟁 판이 바뀐다
- [보험사 IFRS17 조기도입 명암]MG손보, 자본잠식 벗어났지만 결손금 두 배 늘었다